Objective
=========

To compare the efficacy and safety of of pregabalin, gabapentin, carbamazepine and topiramat in migraine.

Research design and methods
===========================

In this observational study, 24 patients received pregabalin, gabapentin, carbamazepine and topiramat orally twice daily, each for 6 month with optional dose up titration (divided in four groups, each group has 6 patients). Pain diagnosis of migraine was made according to the second edition of the International Classification of Headache Disorders (ICHD-2) criteria and pain relief was measured by the patient's global assessment of efficacy, using the Migraine Disability Assessment Questionnaire (MIDAS). Treatment goals include restoring function and improving pain control.

Results
=======

There was a significant improvement in pain with all treatments compared with their baseline values. There were no significant differences in various other outcome measures between the groups.

Conclusions
===========

Both carbamazepine and topiramat demonstrated similar efficacy in migraine but pregabalin, gabapentin was less effective on pain.
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